Biggest News Aggregation in the World
📰 Advanced Solid Tumors News

Page 8 - Advanced Solid Tumors News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Advanced Solid Tumors. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

BridgeBio Announces Clinical Collaboration with Amgen to Study BBP-398, a Potentially Best-in-class SHP2 Inhibitor, in Combination with LUMAKRAS® (sotorasib) in Advanced Solid Tumors with the KRAS G12C Mutation | Small Molecules

BridgeBio Announces Clinical Collaboration with Amgen to Study BBP-398, a Potentially Best-in-class SHP2 Inhibitor, in Combination with LUMAKRAS® (sotorasib) in Advanced Solid Tumors with the KRAS G12C Mutation
Frank Mccormick Anderson Cancer Center Therapeutics Discovery I Bridgebio Pharma Inc Amgen Inc University Of Texas Bristol Myers Squibb

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

Study to evaluate ATG-101, a proprietary PD-L1/4-1BB bispecific antibody Study will enroll patients with Metastatic/Advanced Solid Tumors and Mature B-Cell Non-Hodgkin Lymphomas SHANGHAI and HONG KONG, Dec. 20, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, to...
South Korea New South Wales Kevin Lynch Charlotte Lemech Asia Pacific Peter Qian

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science